It has been reported to inhibit glucagon-mediated hyperglycemia in vivo.75 Another researcher reported the inhibition of hyperglycemia activity mediated by increased glucose production.76 Findings suggested that in the clinical aspect, glycogen phosphorylase inhibitors (Figure 11A) may be more successful against fasting rather than a prandial condition. The gene discussed is GCG; the disease is Hyperglycemia.